Results 91 to 100 of about 11,928,997 (202)

Molecular dynamics of select missense mutations of Apolipoprotein E and their implications in Hyperlipoproteinemia type III

Apolipoprotein E (Apo E) is involved in lipid metabolism and plays a crucial role in maintaining the balance of lipoprotein interactions within the body.
Ranvir Singh, Sumit Thakur, Balvinder Singh   +2 more
core   +1 more source

Bryon II

, 1994
Chef John Sarich of Chateau St ...
Bryon II
core  

Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia

, 1986
A variant of apolipoprotein E, denoted apo E3-Leiden, has been identified in a 41-year-old male suffering from type III hyperlipoproteinemia with xanthomatosis. Apo E3-Leiden focus in the E3 position.
Havekes, L., Gevers Leuven, J., Wit, E.de   +2 more
core  

Characterization with zonal ultracentrifugation of LDL in type V hyperlipoproteinemia

, 1984
Low-density lipoproteins (density = 1.019-1.063 g/ml) were isolated in 10 subjects with type V hyperlipoproteinemia by ultracentrifugation in a zonal rotor under rate flotation conditions.
G. Baggio, MANZATO, ENZO, G. Baldo, G. Crepaldi, MARIN, RAFFAELLA, A. Gasparotto   +5 more
core  

Byron II Presents Quail Ridge

, 1994
Wine "Ms.
Byron II
core  

Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia

, 1991
After 15 weeks of simvastatin therapy (20 mg/day), low density lipoprotein particle size in sera of 16 patients with type IIb hyperlipoproteinemia increased significantly from 233 ± 5.0 Å to 237 ± 7.0 Å (P < 0.05), analyzed by 2–16% polyacrylamide ...
Hooft, F.M. van 't, Gevers Leuven, J.A., Zhao, S.P., hollar, L., Smelt, A.H.M., Laarse, A. van der   +5 more
core  

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia

Arquivos Brasileiros de Cardiologia
Maria Cristina de Oliveira Izar, Francisco Antonio Helfenstein Fonseca   +1 more
doaj   +1 more source

A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate. [PDF]

J Atheroscler Thromb
Otsuki T, Chung Y, Kawachi Y, Komuku S, Yamanishi M, Takano T, Yamaguchi A, Hanada H, Masuda D, Miyashita K, Yamashita S.   +10 more
europepmc   +1 more source

Pharmacology of Diabetes Type II Dentistry implications

, 2017
Diabetes mellitus type II is a late onset. its multifactorial for example obesity, smoking, low birth weight. Gestational diabetes can be associated with it and also genetics can be a key role.
Meliou, Maria
core  

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait. [PDF]

Curr Opin Lipidol
Hegele RA.
europepmc   +1 more source